Osteri 750mg

Osteri 750mcg Teriparatide 750 mcg Injection is a medication used to treat:

• Osteoporosis (a condition characterized by brittle and fragile bones)
• Postmenopausal osteoporosis (a condition characterized by bone loss and osteoporosis that occurs after menopause)
• Glucocorticoid-induced osteoporosis (a condition characterized by bone loss and osteoporosis that occurs as a side effect of long-term glucocorticoid therapy)

Composition: Each injection of Osteri contains 750 mcg of Teriparatide (an active pharmaceutical ingredient), which is a synthetic form of human parathyroid hormone (PTH).

Mechanism of Action: Teriparatide works by:

• Mimicking the action of PTH, which stimulates bone formation and resorption
• Increasing bone density and strength by stimulating osteoblasts (cells that produce bone tissue)
• Reducing the rate of bone loss and fracture risk

Dosage: The recommended dose of Osteri is:

• 20 mcg injected subcutaneously (under the skin) once daily, for the treatment of osteoporosis
• The dose should be adjusted according to patient response and tolerance

Side Effects: Common side effects of Osteri include:

• Nausea or vomiting
• Headache or dizziness
• Muscle pain or weakness
• Fatigue or insomnia
• Constipation or diarrhea
• Rash or itching

Rare but serious side effects include:

• Hypocalcemia (low levels of calcium in the blood)
• Hypercalcemia (high levels of calcium in the blood)
• Urticaria (hives)
• Stevens-Johnson syndrome (a severe skin and mucous membrane reaction)

Recommendation: Osteri is recommended for patients with osteoporosis, postmenopausal osteoporosis, or glucocorticoid-induced osteoporosis who have not responded to other treatments or who have had unacceptable side effects. Patients with kidney disease or other medical conditions that may affect their ability to respond to treatment should be closely monitored while taking Osteri.

Important Note:

• Osteri should be used under the guidance of a healthcare provider with experience in the treatment of osteoporosis.
• Patients should be advised to report any symptoms of hypersensitivity reactions, such as rash, itching, swelling, or difficulty breathing.
• Osteri may interact with other medications, such as certain antibiotics and antacids. Patients should inform their healthcare provider of all medications they are taking before starting Osteri therapy.
• Patients with a history of kidney disease or other medical conditions that may affect their ability to respond to treatment should be closely monitored while taking Osteri.

Special Precautions:

• Patients with kidney disease should be closely monitored while taking Osteri.
• Pregnant or breastfeeding women should consult their healthcare provider before taking Osteri.
• Patients with a history of gastrointestinal problems, such as dyspepsia or gastritis, should be monitored while taking Osteri.